natgillin/translations-raw huggingface dataset:
Past rail research and innovation efforts at EU level have not succeeded in supporting new technologies enabling the further integration of diverse national railway ecosystems and of different rail subsystems.
Pretekla prizadevanja na področju raziskav in inovacij na ravni EU niso uspela zagotoviti podpore novim tehnologijam, ki bi omogočale nadaljnje povezovanje različnih nacionalnih železniških ekosistemov in različnih železniških podsistemov.
Past this period, the creditor will in principle be entitled to compensation of 5% of the amount specified, in addition to the interest for late payment and the compensation for recovery costs.
Po zaključku tega obdobja bo upnik načeloma upravičen do nadomestila v višini 5 % določenega zneska, poleg obresti za zamude pri plačilu in nadomestila za stroške izterjave.
pasta and pizza products in all forms,
izdelke iz testenin in pice v vseh oblikah;
Pasta prices are set to rise by 20% owing to a biofuel maize boom.
Zaradi razcveta uporabe koruze za biogorivo se bodo testenine podražile za 20 %.
Pasta prices are set to rise by 20% owing to a biofuel maize boom.
Zaradi razcveta uporabe koruze za biogorivo se bodo testenine podražile za 20 %.
pasta,
testenine;
Pasta, whether or not cooked or stuffed
Testenine, kuhane ali nekuhane ali polnjene
Pasta, whether or not cooked or stuffed (with meat or other substances) or otherwise prepared such as spaghetti, macaroni, noodles, lasagne, gnocchi, ravioli, cannelloni, except pasta falling within CN codes 1902 20 10 and 1902 20 30, couscous, whether or not prepared
Testenine, kuhane ali nekuhane ali polnjene (z mesom ali drugimi snovmi) ali drugače pripravljene, kot so špageti, makaroni, rezanci, lazanje, cmoki, ravioli, kaneloni; kuskus, pripravljen ali nepripravljen
Pasta, whether or not cooked or stuffed (with meat or other substances) or otherwise prepared, such as spaghetti, macaroni, noodles, lasagne, gnocchi, ravioli, cannelloni, couscous, whether or not prepared, excluding stuffed pasta falling within CN codes 1902 20 10 and 1902 20 30
Testenine, kuhane ali nekuhane ali polnjene (z mesom ali drugimi snovmi) ali drugače pripravljene, kakršne so špageti, makaroni, rezanci, lazanje, cmoki, ravioli, kaneloni, kuskus, pripravljen ali nepripravljen, razen polnjenih testenin iz tarifnih oznak 1902 20 10 in 1902 20 30
Pasta, whether or not cooked or stuffed (with meat or other substances) or otherwise prepared, such as spaghetti, macaroni, noodles, lasagne, gnocchi, ravioli, cannelloni; couscous, whether or not prepared:
Testenine, kuhane ali nekuhane ali polnjene (z mesom ali drugimi snovmi) ali drugače pripravljene, kot so: špageti, makaroni, rezanci, lazanje, cmoki, ravioli, kaneloni; kuskus; pripravljen ali nepripravljen:
Pasta, whether or not cooked or stuffed (with meat or other substances) or otherwise prepared, such as spaghetti, macaroni, noodles, lasagne, gnocchi, ravioli, cannelloni; couscous, whether or not prepared:
Testenine, kuhane ali nekuhane ali polnjene (z mesom ali drugimi snovmi) ali drugače pripravljene, kot so: špageti, makaroni, rezanci, lazanje, njoki, ravioli, kaneloni; kuskus; pripravljen ali nepripravljen:
Pastis contains less than 100 grams of sugars per litre, expressed as invert sugar, and has a minimum and maximum anethole level of 1.5 and 2 grams per litre, respectively.
Pastis vsebuje manj kot 100 gramov sladkorjev na liter, izraženih kot invertni sladkor, in ima vsebnost anetola med 1,5 in 2 gramoma na liter.
Pastis contains less than 100 grams of sugar per litre and has a minimum and maximum anethole level of 1,5 and 2 grams per litre respectively.
Pastis vsebuje manj kot 100 gramov sladkorja na liter in ima najmanjšo in največjo vrednost anetola 1,5 in 2 grama na liter.
Pastis de Marseille is a pastis with an anethole content of 2 grams per litre.
Pastis de Marseille je pastis z vsebnostjo anetola 2 grama na liter.
Pastis de Marseille is a pastis with an anethole content of 2 grams per litre.
Pastis de Marseille je pastis z deležem anetola 2 grama na liter.
Pastis is an aniseed-flavoured spirit drink which also contains natural extracts of liquorice root (Glycyrrhiza glabra), which implies the presence of the colorants known as 'chalcones' as well as glycyrrhizic acid, the minimum and maximum levels of which must be 0,05 and 0,5 grams per litre respectively.
Pastis je žgana pijača z okusom janeža, ki vsebuje tudi naravne ekstrakte golostebelnega korena (Glycyrrhiza glabra), pri čemer morajo biti navzoča barvila, poznana kot „halkoni“ in glicirizinska kislina, katere najmanjše in največje vrednosti morajo znašati 0,05 in 0,5 grama na liter.
Pastis is an aniseed-flavoured spirit drink which also contains natural extracts of liquorice root (Glycyrrhiza spp.), which implies the presence of the colorants known as ‘chalcones’ as well as glycyrrhizic acid, the minimum and maximum levels of which must be 0.05 and 0.5 grams per litre, respectively.
Pastis je žgana pijača z aromo janeža, ki vsebuje tudi naravne ekstrakte golostebelnega korena (Glycyrrhiza spp.), pri čemer morajo biti navzoča barvila, poznana kot „halkoni“, in glicirizinska kislina, katere najmanjša vsebnost mora znašati 0,05, največja pa 0,5 grama na liter.
Pasztor (HU-II)
PÁSZTOR (HU-II)
patch application software within 48 hours;
popravijo programje aplikacij v 48 urah;
patch system software within 48 hours; and
popravijo sistemsko programje v 48 urah;
Patent applications in Future and Emerging Technologies
Patentne prijave v prihodnjih in nastajajočih tehnologijah
Patent applications in the area of the different Societal Challenges
Prijave patentov na področju različnih družbenih izzivov
Patent applications obtained in the different enabling and industrial technologies
Uporaba patentov razvitih na področju omogočitvenih in industrijskih tehnologij
Patent costs can easily reach EUR 32 000, according to Commission estimates, whereas in the US they are just EUR 1 850.
Po ocenah Komisije stroški patentov zlahka dosežejo 32 000 EUR, medtem ko v ZDA znašajo zgolj 1850 EUR.
Patent Fuel Plants:
Briketarne
Patent law harmonisation could make it easier for European companies to patent their inventions outside the EU.
Uskladitev patentnega prava lahko evropskim podjetjem olajša patentiranje njihovih izumov zunaj EU.
Patent leather and patent laminated leather; metallised leather
Lakasto usnje ali lakasto plastovito usnje, metalizirano usnje
Patent litigation costs in selected Member States
Stroški patentnega spora v izbranih državah članicah
Patent litigation in the EU is unnecessarily costly for all parties involved.
Patentni spor v EU je po nepotrebnem drag za vse udeležene stranke.
Patent litigation insurance
Zavarovanje v patentnem sporu
Patent litigation statistics
Statistika patentnih sporov
Patent protection, for instance, is essential for the development of new groundbreaking drugs or medical equipment.
Zaščita patentov je na primer bistvenega pomena za razvoj novih revolucionarnih zdravil oziroma medicinske opreme.
Patent reform agenda
Agenda patente reforme
Patent rights and plant variety rights conflict with each other for a number of reasons.
Patentne in žlahtniteljske pravice so iz različnih razlogov v medsebojnem nasprotju.
Patent-related rights
Pravice v zvezi s patenti
Patenting remains excessively complicated and costly in Europe, and fragmented litigation fails to provide sufficient legal certainty.
Patentiranje je v Evropi izredno zapleteno in drago, razdrobljeni sodni postopki pa ne zagotavljajo zadostne pravne varnosti.
Patents and trade marks are the best-known industrial property rights.
Patenti in blagovne znamke so najbolj znane pravice industrijske lastnine.
Patents applications generated by European fusion laboratories
Vloge za patente, ki so jih razvili evropski fuzijski laboratoriji.
Patents are a driving force for promoting innovation, growth and competitiveness.
Patenti so gonilna sila spodbujanja inovacij, rasti in konkurenčnosti.
Patents are a limited-term exclusive right granted to an inventor in return for the disclosure of technical information from the invention.
Patenti so časovno omejena izključna pravica, podeljena izumitelju za razkritje tehničnih informacij o izumu.
Patents are also extremely expensive to defend.
Tudi zaščita patentov je izredno draga.
Patents may cover inventions relating to the methods used by GNSS receivers for capturing and demodulating the signals and for the related processing algorithms.
Patenti lahko vključujejo inovacije, povezane z metodami, ki jih uporabljajo sprejemniki GNSS za lovljenje in demodulacijo signalov ter za s tem povezane obdelovalne algoritme.
Patents – a statutory monopoly;
patenti – zakoniti monopol;
patents,
patenti,
patents, development activities or inventions;
patenti, razvojne dejavnosti ali izumi;
Pater
g.
Pater (GRIII-PL)
Krzysztof PATER (PL-III)
Pater (PL – III)
CABRA DE LUNA (ES-III)
Pater (PL-Gr.
PATER (PL-III)
Pater (PL-III)
D'sa (UK-III)
PATER (PL-III) (Rule 62 OLSSON)
PATER (PL-III) (OLSSON, člen 62)
Pater (PL-III) (Rule 62 – Hoffelt)
PATER (PL-III) (Hoffelt, člen 62)
Pater (PL-III) (Rule 62 – Hoffelt)
PATER (PL-III) (člen 62 – g.
PATER (Rule 62 – Reckinger) (PL-III)
RECKINGER, člen 62) (PL-III)
PATER Krysztof, President of ECO section **
PATER Krysztof, predsednik strokovne skupine ECO
Patetta Gaëlle (for the rapporteur)
(za poročevalca)
Path towards achieving the main Lisbon objectives
Pot k uresničitvi glavnih lizbonskih ciljev
Pathogens or pests can be eliminated on arrival by sanitary control measures.
Patogeni ali škodljivci se lahko ob prihodu odstranijo s pomočjo sanitarnih nadzornih ukrepov.
Pathological (addictive) gambling has been considered by some specialists as an impulse control disorder68 and therefore not referred to as addiction.
Patološko igranje na srečo (ki povzroča zasvojenost) nekateri strokovnjaki štejejo za motnjo nadzora impulzov68 in torej ne za obliko zasvojenosti.
Pathological, zootechnical, physiological and ethological aspects
Patološki, zootehnični, fiziološki in etološki vidiki
Pathway 1: tackling contractual segmentation
Pristop 1: reševanje problema segmentacije pogodb
Pathway 2: developing flexicurity within the enterprise and offering transition security.
Pristop 2: razvijanje prožne varnosti v okviru podjetij in zagotavljanje varnosti med prehodnimi obdobji
Pathway 3: tackling skills and opportunity gaps among the workforce
Pristop 3: odpravljanje pomanjkanja spretnosti in znanj ter priložnosti znotraj delovne sile
Pathway 4: improving opportunities for benefit recipients and informally employed workers.
Pristop 4: izboljšanje možnosti prejemnikov nadomestil in neformalno zaposlenih delavcev
Pathways
Poti
Pathways for Inclusion
Ukrepi za vključevanje
pathways from VET to HE accessible to groups at risk;
omogoči dostopne poti med poklicnim izobraževanjem in usposabljanjem ter visokim šolstvom za ogrožene skupine;
pathways to integration and re-entry into employment for disadvantaged people such as, people experiencing social exclusion, early school leavers, minorities, and people with disabilities and people providing care for dependent persons, through employability measures, including in the field of the social economy, access to vocational education and training, and accompanying actions and relevant social support, community and care services that improve employment opportunities;
možnosti in načinov vključevanja v zaposlovanje in ponovnega zaposlovanja za prikrajšane ljudi, kot so ljudjei, ki so bili socialno izključeni, ljudjei, ki so predčasno opustili šolanje, manjšine, in ljudjei, nezmožni za delo, ter ljudje, ki skrbijo za svoje vzdrževance, s pomočjo zaposlitvenih ukrepov, tudi na področju socialnega gospodarstva, dostopa do poklicnega izobraževanja in usposabljanja ter spremljevalnih ukrepov in ustrezne socialne podpore, storitev skupnosti ter skrbstvenih storitev, ki izboljšajo zaposlitvene možnosti;
pathways to integration in employment for disadvantaged people, people experiencing social exclusion, early school leavers, minorities and people with disabilities, through employability measures, including in the field of the social economy, accompanying actions and relevant social support and care services;
možnosti in načini vključevanja v zaposlovanje za prikrajšane ljudi, ljudi, ki so bili socialno izključeni, ljudi, ki so predčasno opustili šolanje, manjšine in ljudi, nezmožne za delo, s pomočjo zaposlitvenih ukrepov, tudi na področju socialnega gospodarstva, spremljevalnih ukrepov in ustrezne socialne podpore ter skrbstvenih storitev;
Patient and health-sector professional representative bodies will therefore need to be involved in shaping the process of developing and funding these new technologies.
Njihove predstavniške organizacije in organizacije zdravstvenih delavcev je treba vključiti v opredeljevanje načinov razvoja in financiranja teh novih tehnologij.
Patient associations and medical surgeons with scientific experience of advanced therapy medicinal products should also be represented.
Zastopana morajo biti tudi združenja bolnikov in kirurgov z znanstvenimi izkušnjami z zdravili za napredno zdravljenje.
Patient associations and surgeons with scientific experience of advanced therapy medicinal products should also be represented.
Zastopana morajo biti tudi združenja bolnikov in kirurgov z znanstvenimi izkušnjami z zdravili za napredno zdravljenje.
Patient awareness of this information
ali se bolniki zavedajo teh informacij;
Patient awareness of this information
Poznavanje teh informacij pri bolnikih
Patient care plan
Načrt obravnave pacienta
Patient empowerment
Krepitev vpliva in vloge pacientov
Patient mobility in the EU
«Mobilnost bolnikov v EU«
Patient mobility in the EU (communication)
Mobilnost bolnikov v EU (sporočilo)
Patient mobility in the EU (communication)
Mobilnost pacientov v EU (sporočilo)
Patient must be involved in pharmacovigilance including direct reporting of suspected adverse reactions.
Paciente je treba vključiti v farmakovigilanco, vključno z neposrednim pacientovim poročanjem o domnevnih neželenih učinkih.
Patient organisations and civil society should play a prominent role in building solutions.
Organizacije pacientov in civilna družba morajo igrati pomembno vlogo pri oblikovanju rešitev.
Patient registries and databases constitute important instruments to serve research in the field of rare diseases and to improve patient care and healthcare planning.
Registri pacientov in zbirke podatkov o pacientih so pomembni instrumenti za raziskave na področju redkih bolezni ter izboljšanje oskrbe pacientov in načrtovanja na področju zdravstvenega varstva.
patient rights
pravice bolnikov;
Patient safety
Varnost pacientov
Patient safety - prevention and control of healthcare associated infections
Varnost pacientov, vključno s preprečevanjem in obvladovanjem okužb, povezanih z zdravstveno oskrbo
Patient safety and transparency of information
Varnost bolnikov in preglednost informacij
patient safety embedded in the education and training of health professionals; and
varnost pacientov, vključena v izobraževanje in usposabljanje zdravstvenih delavcev, in
patient safety in non-hospital care;
varnost pacientov v zunajbolnišnični oskrbi;
Patient safety is a further key area of concern.
Nadaljnje ključno področje ukrepanja je varnost bolnikov.
Patient safety is defined by WHO as freedom for a patient from unnecessary harm or potential harm associated with healthcare.
Svetovna zdravstvena organizacija varnost pacientov opredeljuje kot pravico pacientov do varstva pred nepotrebnimi ali morebitnimi škodljivimi posledicami, povezanimi z zdravstvenim varstvom.
Patient safety is not widely embedded in the undergraduate and postgraduate education of healthcare workers, on-the-job-training and the continuing professional education of health professionals, except in six Member States.7 In eight Member States, it is not formally required at any level or for any health professionals.
Varnost pacientov ni široko vključena v dodiplomsko in podiplomsko izobraževanje delavcev v zdravstvu, usposabljanje na delovnem mestu in stalno strokovno izobraževanje zdravstvenih delavcev, razen v šestih državah članicah.7 V osmih državah članicah se to uradno ne zahteva na nobeni ravni ali za nobene zdravstvene delavce.
Patient safety is seen as a result of good quality healthcare.
Varnost pacientov je obravnavana kot rezultat dobre kakovosti zdravstvene oskrbe.
patient safety policies and programmes (21 replies);
politike in programi o varnosti pacientov (21 odgovorov);
Patient safety should be embedded in the education and training of healthcare workers, as the providers of care.
Varnost pacientov mora biti vključena v izobraževanje in usposabljanje delavcev v zdravstvu, ki zagotavljajo oskrbo.
Patient safety standards are mandatory in 20 countries (11 in 2012) and recommended in four others.
Standardi varnosti pacientov so obvezni v 20 državah (11 leta 2012) in priporočeni v nadaljnjih štirih.
patient safety strategies;
strategije za varnost pacientov;
Patient safety/prevention of healthcare associated infections
Varnost pacientov, vključno s preprečevanjem in obvladovanjem okužb, povezanih z zdravstveno oskrbo
Patient safety1 is an issue of increasing concern in healthcare systems all over the world.
Vprašanje varnosti pacientov1 postaja vse pomembnejše v sistemih zdravstvenega varstva po vsem svetu.
Patients and doctors from beyond the panel of experts should be able to make their voices heard, ask the questions that worry them, and sound the alarm.
Bolnikom in zdravnikom zunaj kroga strokovnjakov je treba omogočiti, da izrazijo svoje mnenje, zastavijo vprašanja, ki jih vznemirjajo, in opozarjajo.
Patients and healthcare professionals do not have access to essential information on clinical investigations and evidence;
pacienti in zdravstveni delavci nimajo dostopa do pomembnih informacij o kliničnih raziskavah in dokazih;
Patients and healthcare professionals need accurate and well communicated information about the risks associated with both the medicinal product, and the condition for which it is being used.9
Pacienti in zdravstveni delavci potrebujejo natančne in pravilno sporočene informacije o tveganjih, povezanih z zdravilom, in o stanju, za katerega se zdravilo uporablja9.
Patients and healthcare professionals need accurate and well communicated information about the risks associated with both the medicinal product, and the condition for which it is being used.9
Pacienti in zdravstveni delavci potrebujejo natančne in pravilno sporočene informacije o tveganjih, povezanih z zdravilom, in o stanju, zakaterega se uporablja9.
Patients and healthcare professionals should be encouraged to report all suspect adverse reactions to such medicinal products, and a publicly available list of such medicinal products should be kept up to date by the Agency.
Bolnike in zdravstvene delavce je treba spodbujati, da poročajo o vseh domnevnih neželenih učinkih takih zdravil, Agencija pa mora sproti dopolnjevati javno dostopen seznam takih zdravil.
Patients and healthcare professionals should be encouraged to report all suspect adverse reactions to such medicinal products, and a publicly available list of such medicinal products should be maintained up to date by the European Medicines Agency established by Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency12 (hereinafter referred to as the ‘Agency’).
Bolnike in zdravstvene delavce je treba spodbujati, da poročajo o vseh domnevnih neželenih učinkih takih zdravil, Evropska agencija za zdravila, ustanovljena z Uredbo (ES) št. 726/2004 Evropskega parlamenta in Sveta z dne 31. marca 2004 o postopkih Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za humano in veterinarsko uporabo ter o ustanovitvi Evropske agencije za zdravila12 (v nadaljnjem besedilu: Agencija), pa mora vzdrževati ažuren javno dostopen seznam takih zdravil.
Patients and patients’ representatives should therefore be involved at all steps of the policy and decision-making processes.
Zato morajo biti bolniki in njihovi predstavniki vključeni na vsaki stopnji postopka oblikovanja politike in odločanja.
Patients are always inclined to scrutinise health information particularly closely.
Bolniki navadno informacije s področja zdravstva še posebej skrbno preverjajo.
patients as the users of medicines and families and carers as advisers and carers of patients,
bolniki kot uporabniki zdravil ter družine in negovalno osebje kot svetovalci in negovalci bolnikov,
Patients cannot be considered as mere consumers of medicines and of medical care, because their rights are not purely economic, and are comparable only with the right to justice or the right to education, which states uphold by providing services of general interest.
Pacientov ne smemo obravnavati le kot potrošnike zdravil in zdravniških uslug, saj njihove pravice niso izključno gospodarske narave in se lahko primerjajo le s pravico do uporabe pravnih sredstev in pravico do izobraževanja, kar se odraža v zagotavljanju storitev splošnega pomena s strani držav.
Patients could receive important stimuli for such changes if health professionals included in routine contacts practical advice to patients and families on the benefits of optimal diets and increased levels of physical activity.
Bolniki bi lahko prejeli spodbude za take spremembe, če bi strokovnjaki za zdravje vključili v svoj običajni potek dela praktične nasvete bolnikom in družinam glede prednosti, ki jih imajo zdrava prehrana in povečana telesna dejavnost.
Patients could receive information on the status of a particular health professional only through the assistance of national contacts points and within the limits imposed by the principles of data protection and presumption of innocence.
Pacienti bi lahko informacije o statusu določenega zdravstvenega delavca prejemali samo prek nacionalnih kontaktnih točk in v okviru omejitev, ki jih določata načeli varstva podatkov in domneve nedolžnosti.
Patients do not have sufficient information on pharmacovigilance;
bolniki niso dovolj obveščeni o farmakovigilanci;
patients do not have sufficient information on pharmacovigilance;
da bolniki nimajo zadostnih informacij o farmakovigilanci;
Patients do not have sufficient information on pharmacovigilance;
pacienti niso dovolj obveščeni o farmakovigilanci;
Patients even pay twice, first due to delayed access and second due to financial compensations paid by taxpayers’ money.
Pacienti plačajo celo dvakrat, prvič zaradi odloženega dostopa in drugič zaradi finančnih nadomestil, ki se plačajo z davkoplačevalskim denarjem.
Patients faced with a proliferation of players may feel they have greater autonomy as individuals or, on the other hand, they may become totally dependent on their doctor, depending on the level of their knowledge and understanding of the system.
Pacienti, soočeni z velikim številom izvajalcev zdravstvenega varstva, imajo lahko občutek, da je njihova samostojnost pri odločanju res upoštevana, ali pa nasprotno postanejo povsem odvisni od svojega zdravnika – to je odvisno od tega, kako dobro sistem poznajo in razumejo.
Patients faced with a proliferation of players may feel they have greater autonomy as individuals or, on the other hand, they may become totally dependent on their doctor, depending on the level of their knowledge and understanding of the system.
Pacienti, soočeni z velikim številom izvajalcev zdravstvenega varstva, imajo lahko občutek, da je njihova samostojnost pri odločanju res upoštevana, ali pa nasprotno postanejo povsem odvisni od svojega zdravnika, glede na to, kako dobro sistem poznajo in razumejo.
patients from other Member States shall enjoy equal treatment with the nationals of the Member State of treatment, including the protection against discrimination provided for according to Community law and national legislation in force in the Member State of treatment.
pacientom iz drugih držav članic je zagotovljeno enako zdravljenje kot državljanom države članice zdravljenja, vključno z zaščito pred diskriminacijo, zagotovljeno v skladu z zakonodajo Skupnosti in veljavno zakonodajo države članice zdravljenja.